Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
2012 · Nature · 1,103 citations
https://doi.org/10.1038/nature11249
J
Jane Fridlyand
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
202
Papers
20.2K
Citations
46
h-index
59
i10-index
Jane Fridlyand is an academic researcher from Systems Analytics (United States). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Cells and Metastasis & Genomic variations and chromosomal abnormalities. The author has an h-index of 46, co-authored 172 publications.
Papers by this author
worksA prediction-based resampling method for estimating the number of clusters in a dataset
2002 · Genome biology · 703 citations
https://doi.org/10.1186/gb-2002-3-7-research0036
Breast tumor copy number aberration phenotypes and genomic instability
2006 · BMC Cancer · 291 citations
https://doi.org/10.1186/1471-2407-6-96
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
2007 · Breast Cancer Research · 78 citations
https://doi.org/10.1186/bcr1765
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples
2014 · Breast Cancer Research and Treatment · 25 citations
https://doi.org/10.1007/s10549-014-3163-8
Statistical techniques to construct assays for identifying likely responders to a treatment under evaluation from cell line genomic data
2010 · BMC Cancer · 1 citations
https://doi.org/10.1186/1471-2407-10-586
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat